Rare diseases
Investigational molecules
Locations
777 Old Saw Mill River Road, 10591-6717, United States
Regeneron Pharmaceuticals Inc. funds extensive research in non-small cell lung cancer, including advanced, resectable, and biomarker-defined disease, alongside studies in melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, ovarian cancer, and other advanced solid tumors. Its oncology portfolio also includes multiple programs in multiple myeloma, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, and high-risk monoclonal gammopathy of undetermined significance.
Additional oncology interests extend to head and neck squamous cell carcinoma, endometrial cancer, renal-cell carcinoma, primary peritoneal cancer, and perioperative treatment strategies for surgically managed malignancies.
Regeneron Pharmaceuticals Inc. runs clinical trials in conditions such as Embolism, Non-small cell lung cancer, Malignant melanoma, Plasma cell myeloma refractory, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
Greece
BelgiumBelgiumBelgium
AustriaBulgariaAustriaBelgium
FranceFranceGreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
